Navigation Links
Subsidiary of Nova Biomedical Completes Acquisition of Assets of CCS Medical's Subsidiary, Sanvita, Inc.
Date:10/7/2009

WALTHAM, Mass., Oct. 7 /PRNewswire/ -- Nova Biomedical Corporation, a leading developer of whole blood analyzers, today announced that the company's independent, wholly owned subsidiary, Sanvita CBGM, LLC, has completed the acquisition of certain assets of Sanvita, Inc., a subsidiary of CCS Medical, Inc.

Nova Biomedical is the sole manufacturer, and through this transaction, Nova's Consumer Blood Glucose Monitoring (CBGM) subsidiary has become the exclusive distributor, of the "NovaMax" consumer blood glucose product line in the United States. The NovaMax blood glucose monitor has the fastest test time and absolutely no coding.

"We are excited to have completed the highly complementary acquisition of these assets of Sanvita, Inc., which allows our CBGM subsidiary to assume full control of the distribution of our NovaMax brand," said Francis C. Manganaro, President and Chief Executive Officer of Nova Biomedical. "We are confident that this transaction better positions Nova Biomedical and Sanvita CBGM to streamline the development and delivery of NovaMax products for the benefit of customers. Together with the recent success of Nova Biomedical's hospital glucose monitor business, StatStrip, the company is better positioned to further improve its overall glucose monitoring business. We also look forward to continuing our partnership with CCS Medical and to a seamless integration of the NovaMax distribution business into Sanvita CBGM."

Additional information regarding the transaction has been filed with the United States Bankruptcy Court for the District of Delaware and can be found at the Court's website, www.deb.uscourts.gov.

About Sanvita CBGM, LLC

Sanvita CBGM, LLC is an independent, wholly owned subsidiary of Nova Biomedical and the exclusive distributor of NovaMax products in the United States.

About Nova Biomedical

Nova Biomedical is a world leader in the development of whole blood analyzers to support the care of home based and hospitalized patients. Based upon innovative biosensor technology, Nova glucose monitors are designed for rapid and accurate measurement of patient glucose levels without coding test strips. Nova Biomedical has pioneered many advances in glucose testing and introduced its first glucose whole blood biosensor to hospitals in 1987.

Contacts:

For Nova Biomedical:

    John C. Swan
    Treasurer
    Nova Biomedical Corporation
    781-894-0800

SOURCE Nova Biomedical Corporation


'/>"/>
SOURCE Nova Biomedical Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. New Places and People - Truphatek opens USA subsidiary
2. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Files Three Patent Applications
3. Cantel Medical Corp.s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products
4. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
5. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
6. OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
7. NIH Funds New Wellstone Research Center for Muscular Dystrophy at Boston Biomedical Research Institute
8. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
9. Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications
10. Saladax Biomedicals 5-FU Personalized Chemotherapy Management (PCM(R)) Assay CE Marked for Distribution in the EU
11. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... The Board of Directors of NeuroVive Pharmaceutical ... which is to take place on Thursday, April 27, 2017, at ... Sweden . ... Please see the attached notification, which is being announced within short ... Pharmaceutical AB (Publ) The Board Of Directors About NeuroViveNeuroVive ...
(Date:3/22/2017)... Israel, March 22, 2017  DarioHealth Corp. (NASDAQ: ... mobile health and big data solutions, today reported ... twelve month period ended December 31, 2016. ... of $2.8 million, increased 241% compared to the ... revenue growth throughout the entire year  ...
(Date:3/22/2017)... Serve You Rx Vermont, LLC, a wholly owned ... based in Milwaukee, Wisconsin , has acquired ... Middlebury, Vermont , from Pharmacy Health Services, ... it was perfect timing for this opportunity to present itself," ... You. "Like us, NEMOP has a high-touch service model, which ...
Breaking Medicine Technology:
(Date:3/23/2017)... Washington, D.C. (PRWEB) , ... March 23, 2017 ... ... (LEAD Coalition) stands with all Americans facing life-altering and fatal diseases in ... proposed budget makes shortsighted decisions that would eviscerate care, services, and hope for ...
(Date:3/23/2017)... Marina del Rey, CA (PRWEB) , ... March ... ... version of its customizable coding audit software solution, iCode Assurance, at HCCA’s 21st ... iCode Assurance optimizes and accelerates the coding audit process for all medical chart ...
(Date:3/23/2017)... ... 2017 , ... Ogden Clinic, the largest multi-specialty group in ... to expand its focus on patient care by providing an advanced check-in and ... Ogden Clinic, we are working to become a different type of provider, one ...
(Date:3/22/2017)... Australia (PRWEB) , ... March 23, 2017 , ... Death ... a nurse by profession, author Joy Nugent was inspired to write the book titled ... came from her inward desire to make sense of what she was experiencing at ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... create a PCSK9 inhibitor prior authorization (PA) form for prescribers to improve patients’ ... one of the helpful tools published as part of the article entitled ...
Breaking Medicine News(10 mins):